Shopping Cart
- Remove All
Your shopping cart is currently empty
CDK9-IN-33
🥰Excellent
Catalog No. T210374
CDK9-IN-33 (compound C35) is a potent, selective, and orally bioavailable CDK9 inhibitor with IC50 values of 17.44 nM for CDK9, 160 nM for CDK7, 316.30 nM for CDK2, 1771.00 nM for CDK4, and >10000 nM for CDK6. This compound induces apoptosis (cell apoptosis) and reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1, exhibiting antitumor activity.
CDK9-IN-33
CDK9-IN-33
🥰Excellent
Catalog No. T210374
CDK9-IN-33 (compound C35) is a potent, selective, and orally bioavailable CDK9 inhibitor with IC50 values of 17.44 nM for CDK9, 160 nM for CDK7, 316.30 nM for CDK2, 1771.00 nM for CDK4, and >10000 nM for CDK6. This compound induces apoptosis (cell apoptosis) and reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1, exhibiting antitumor activity.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreResource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | CDK9-IN-33 (compound C35) is a potent, selective, and orally bioavailable CDK9 inhibitor with IC50 values of 17.44 nM for CDK9, 160 nM for CDK7, 316.30 nM for CDK2, 1771.00 nM for CDK4, and >10000 nM for CDK6. This compound induces apoptosis (cell apoptosis) and reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1, exhibiting antitumor activity. |
| Targets&IC50 | CDK9:17.44 nM, CDK4:1771.00 nM, CDK2:316.30 nM, CDK7:160 nM, CDK6:>10000 nM |
| In vitro | CDK9-IN-33 (compound C35) at concentrations of 0, 0.01, 0.1, and 1 µM for 24 hours reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1 while enhancing the expression of cleaved PARP. Additionally, CDK9-IN-33 at the same concentrations lowers MCL1 gene mRNA levels. Over 72 hours, CDK9-IN-33 induces apoptosis in a dose-dependent manner. |
| In vivo | CDK9-IN-33 (10 mg/kg; p.o.; daily for 10 days) demonstrates antitumor activity in mice. |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy CDK9-IN-33 | purchase CDK9-IN-33 | CDK9-IN-33 cost | order CDK9-IN-33 | CDK9-IN-33 in vivo | CDK9-IN-33 in vitro
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.